Get the Stockscreener App
258.07
2.64%
6.63
After Hours:
257.90
-0.17
-0.07%
Overview
News
Price History
Option Chain
Financials
Why HUM Down?
Discussions
Forecast
Dividend History
Humana Inc stock is traded at $258.07, with a volume of 3.97M.
It is up +2.64% in the last 24 hours and down -21.37% over the past month.
Humana is one of the largest private health insurers in the us with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
See More
Previous Close:
$251.44
Open:
$246.95
24h Volume:
3.97M
Relative Volume:
2.19
Market Cap:
$30.45B
Revenue:
$112.04B
Net Income/Loss:
$1.71B
P/E Ratio:
10.70
EPS:
24.12
Net Cash Flow:
$-5.05B
1W Performance:
+7.52%
1M Performance:
-21.37%
6M Performance:
-18.41%
1Y Performance:
-47.70%
1-Day Range:
$246.73
$260.48
1-Week Range:
$230.49
$260.48
52-Week Range:
$213.31
$530.54
Humana Inc Stock (HUM) Company Profile
Name
Humana Inc
Sector
Industry
Phone
(502) 580-1000
Address
500 W MAIN ST, LOUISVILLE, KY
Humana Inc Stock (HUM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-26-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jan-25-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-12-23 | Upgrade | Argus | Hold → Buy |
| Nov-08-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-07-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-23-23 | Downgrade | Argus | Buy → Hold |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-13-22 | Upgrade | Goldman | Neutral → Buy |
| Oct-26-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-20-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Initiated | Bernstein | Mkt Perform |
| Apr-13-22 | Upgrade | UBS | Neutral → Buy |
| Jan-06-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-16-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Nov-04-21 | Reiterated | Barclays | Overweight |
| Nov-04-21 | Reiterated | Credit Suisse | Outperform |
| Nov-04-21 | Reiterated | Morgan Stanley | Overweight |
| Nov-04-21 | Reiterated | Oppenheimer | Outperform |
| Nov-04-21 | Reiterated | RBC Capital Mkts | Outperform |
| Sep-27-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Outperform |
| Sep-09-21 | Resumed | Barclays | Overweight |
| Jul-09-21 | Initiated | Seaport Global Securities | Neutral |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Jan-04-21 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Oct-02-20 | Initiated | Bernstein | Mkt Perform |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Jun-16-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jun-05-20 | Initiated | Goldman | Buy |
| Jan-03-20 | Reiterated | JP Morgan | Overweight |
| Oct-18-19 | Initiated | Mizuho | Buy |
| Sep-30-19 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Aug-12-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Apr-23-19 | Initiated | UBS | Neutral |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Dec-20-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-08-18 | Reiterated | BofA/Merrill | Buy |
| Sep-13-18 | Initiated | Barclays | Overweight |
| Jul-12-18 | Resumed | Morgan Stanley | Overweight |
| Jul-06-18 | Reiterated | Piper Jaffray | Overweight |
| Jun-01-18 | Resumed | Citigroup | Buy |
| Feb-08-18 | Upgrade | Credit Suisse | Neutral → Outperform |
| Feb-08-18 | Reiterated | Leerink Partners | Outperform |
| Jan-12-18 | Upgrade | Jefferies | Hold → Buy |
View All
Humana Inc Stock (HUM) Latest News
DECODING DISCOVERY: Cracking the Code on 30(b)(6) Depositions and Data Disputes - TCPAWorld.com
Humana Foundation Contributes Additional $500,000 to Support Disaster Recovery in Florida in the Aftermath of Hurricane Milton - Business Wire
Clover stock gains on Medicare Star Ratings (NASDAQ:CLOV) - Seeking Alpha
Private Advisory Group LLC Has $9.52 Million Position in Humana Inc. (NYSE:HUM) - MarketBeat
US health agency releases 2025 quality ratings for Medicare plans - Reuters
See the list: 7 plans, compared to 38 last year, receive 5 stars in the MA Star Ratings - Healthcare Finance News
Barclays Cuts Humana (NYSE:HUM) Price Target to $250.00 - MarketBeat
Humana’s (HUM) Ratings Plunge Is A Red Flag For Long Term Investors - Yahoo Finance
Humana Inc. (NYSE:HUM) Shares Sold by Tobam - MarketBeat
Humana Ranks #1 Among Health Insurers for Customer Experience for the 4th Year in a Row - Business Wire
Humana Foundation moving headquarters - The Business Journals
UnitedHealth Pre-Q3 Earnings: Golden Opportunity or Fool's Gold? - Benzinga
Humana (NYSE:HUM) Receives Equal Weight Rating from Stephens - MarketBeat
3 Oversold Stocks with Big RSI Rebound Potential - Benzinga
Humana gets a rare stock upgrade at Wall Street amid recent woes - MSN
Traders Purchase High Volume of Call Options on Humana (NYSE:HUM) - MarketBeat
Humana ends selloff as Bernstein upgrades on attractive entry point - Seeking Alpha
Humana (NYSE:HUM) Upgraded by Sanford C. Bernstein to Outperform - MarketBeat
Analyst recommendations: Amex, Humana, Qualcomm, Expedia, Transunion... - Marketscreener.com
Occidental and Humana Are on the Casualty List - GuruFocus.com
Cetera Investment Advisers Sells 4,979 Shares of Humana Inc. (NYSE:HUM) - MarketBeat
Humana Inc. (HUM): Among Seth Klarman’s Top Stock Picks - Yahoo Finance
Humana Stock Getting Closer to 52-Week Lows: A Buying Opportunity? - Benzinga
Humana Stock Getting Closer To 52-Week Lows: A Buying Opportunity? - Barchart
Humana Stock Getting Closer to 52-Week Lows: A Buying Opportunity? - Yahoo Finance
Occidental and Humana Are on the Casualty List - Yahoo Finance
Humana Stock Getting Closer to 52-Week Lows: A Buying Opportunity? - Zacks Investment Research
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Humana Inc. (HUM) on Behalf of Investors - Business Wire
Top Stock Movers Now: Humana, Amazon, Apple, and More - Investopedia
Occidental And Humana Are On The Casualty List - Forbes
Humana (NYSE:HUM) Lowered to Hold at Jefferies Financial Group - MarketBeat
Analyst recommendations: Amex, Exxon Mobil, Garmin, Humana, Netflix... - Marketscreener.com
Sanctuary Advisors LLC Acquires Shares of 8,942 Humana Inc. (NYSE:HUM) - MarketBeat
Jefferies sees downside risk for Humana stock with uncertain Stars appeal trajectory - Investing.com
Jefferies sees downside risk for Humana stock with uncertain Stars appeal trajectory - Investing.com UK
Quality ratings hit to key Medicare plan shakes Humana stock - MSN
Humana Inc. (HUM): Blue-Chip Stock to Buy at 52-Week Lows - Insider Monkey
Humana Inc. (HUM): Blue-Chip Stock to Buy at 52-Week Lows - Yahoo Finance
Northwestern Mutual Wealth Management Co. Purchases 2,986 Shares of Humana Inc. (NYSE:HUM) - MarketBeat
Jim Cramer on Humana Inc. (HUM): ‘If You Can’t Price The Product, Get Out Of The Business’ - Insider Monkey
Jim Cramer on Humana Inc. (HUM): ‘If You Can’t Price The Product, Get Out Of The Business’ - Yahoo Finance
Medicare Mess Sends Humana Shares on Worst Fall Since Financial Crisis - Yahoo Finance
Jim Cramer’s Latest Lightning Round: 10 Stocks to Watch - Insider Monkey
Humana shares sink on Medicare Advantage ratings woes, analyst downgrades - S&P Global
Humana’s bonds may have led its stock as spreads moved back in on Thursday - MarketWatch
3 Oversold Stocks with Strong RSI Rebound Potential - Investing.com
Healthcare of Ontario Pension Plan Trust Fund Purchases 21,225 Shares of Humana Inc. (NYSE:HUM) - MarketBeat
Seth Klarman Stock Portfolio: Top 10 Stock Picks - Insider Monkey
NYSE: HUM Lawsuit against Directors filedInvestors in shares of Humana Inc. (NYSE - Marketscreener.com
NYSE: HUM Lawsuit against Directors filedInvestors in shares of Humana Inc. (NYSE: HUM) should contact the Shareholders Foundation - PR Newswire
Healthcare: Valuations Look Fair Overall, With Select Industries Still Undervalued - Morningstar
Humana Inc Stock (HUM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Humana Inc Stock (HUM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Felter John-Paul W. | SVP, Chief Accting Off & Cont. |
Aug 01 '24 |
Option Exercise |
0.00 |
210 |
0 |
923 |
| Diamond Susan M | Chief Financial Officer |
Aug 01 '24 |
Option Exercise |
0.00 |
311 |
0 |
20,102 |
| Fleming William Kevin | Chief Corporate Aff. Officer |
Feb 22 '24 |
Option Exercise |
0.00 |
3,566 |
0 |
11,553 |
| Deshpande Samir | Chief Information Officer |
Feb 22 '24 |
Option Exercise |
0.00 |
3,770 |
0 |
13,698 |
| BROUSSARD BRUCE D | Chief Executive Officer |
Feb 22 '24 |
Option Exercise |
0.00 |
22,572 |
0 |
96,817 |
| Agrawal Vishal | Chief Strat & Corp Dev Officer |
Feb 22 '24 |
Option Exercise |
0.00 |
3,010 |
0 |
11,845 |
| Ventura Joseph C | Chief Legal Officer |
Feb 22 '24 |
Option Exercise |
0.00 |
3,411 |
0 |
8,181 |
| Huval Timothy S. | Chief Administrative Officer |
Feb 22 '24 |
Option Exercise |
0.00 |
3,712 |
0 |
8,674 |
| Diamond Susan M | Chief Financial Officer |
Feb 22 '24 |
Option Exercise |
0.00 |
3,356 |
0 |
7,436 |
| Renaudin George II | President, Medicare & Medicaid |
Feb 22 '24 |
Option Exercise |
0.00 |
1,104 |
0 |
2,651 |
1.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):